Slingshot members are tracking this corporate initiative:
Cerulean (CERU) Announces Collaboration Agreement with Novartis (NVS) to Develop Nanoparticle-Drug Conjugate (NDC) Product Candidates
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 19, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Strategic Collaboration, Nanoparticle-drug Conjugate, Drug Development, Dynamic Tumor Targeting Technology